Integrative proteomic and metabolomic elucidation of cardiomyopathy with in vivo and in vitro models and clinical samples
Open Access
- 3 September 2024
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 32 (10) , 3288-3312
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82230009, 22374031)
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research (2023YFA1800601)
This publication has 167 references indexed in Scilit:
- New software tools, databases, and resources in metabolomics: updates from 2020Metabolomics, 2021
- Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variantBasic Research in Cardiology, 2021
- The human protein atlas: A spatial map of the human proteomeProtein Science, 2017
- A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathyMetabolomics, 2016
- Metabolic Tracing Using Stable Isotope-Labeled Substrates and Mass Spectrometry in the Perfused Mouse Heart2015
- Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometryAnalytical and Bioanalytical Chemistry, 2012
- HUPO 2011: The New Cardiovascular Initiative ‐ Integrating Proteomics and Cardiovascular Biology in Health and DiseaseProteomics, 2012
- Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older AdultsJAMA, 2010
- Affinity prefractionation for MS‐based plasma proteomicsProteomics, 2009
- Quantitative assessment of human serum high‐abundance protein depletionElectrophoresis, 2008